GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, MET, PPARA, SLC1A1, SRC, TNKS, TNKS2, XDH |
7.86731 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
7.86731 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR |
7.33686 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, RORC, SRC, TYR |
7.24391 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, PPARA |
7.11114 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.11114 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.67486 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
6.54046 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.27255 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR |
6.26586 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
6.17928 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.13388 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.8429 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, XDH |
5.8429 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.75597 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADRB1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.75597 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADRB1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.73621 |
[BP] GO:0032501 |
multicellular organismal process
|
ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HSD11B2, HSD17B2, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR |
5.66917 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, SRC |
5.6371 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, ADRB1, AKR1B1, AXL, BCL2, CA1, CA2, CACNA1C, CDK6, CHRM2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
5.53352 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.26192 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
5.1558 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
5.1558 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, MMP2, RORC, SRC |
5.06955 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.05674 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, AXL, BCL2, CA1, CSNK2A1, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2 |
5.05649 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, HSD11B2, RORC, SRC, TYR |
5.05402 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADRB1, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CACNA1C, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR |
4.99054 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
4.98644 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, ESR1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 |
4.80598 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD11B2, PPARA, SRC |
4.75667 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, AXL, BCL2, CA2, CACNA1C, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR |
4.71942 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
4.69409 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.5967 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.46552 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADRB1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, F3, FLT3, GRM1, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
4.45753 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.31869 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.306 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7 |
4.29832 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.29521 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.27248 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH |
4.19904 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.12619 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.07956 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.02086 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, XDH |
4.00474 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADRB1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESRRA, F3, FABP4, FLT3, GRM1, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
3.91249 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADRB1, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
3.90921 |
[BP] GO:0042592 |
homeostatic process
|
ADRB1, AKR1B1, AXL, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC |
3.86828 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.85868 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, XDH |
3.85868 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, ADRB1, AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TYR |
3.84374 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CACNA1C, CDK6, EGFR, KDR, SRC, TNKS, TNKS2 |
3.7988 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, PIM1, PPARA, TYR, XDH |
3.74374 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FUT7, GBA2, MET, PPARA |
3.72769 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, AURKB, AXL, BCL2, CA2, CDK6, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, MMP2, MMP9, PTPN1, RORC, SRC |
3.68307 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADRB1, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.6792 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADRB1, AKR1B1, AXL, BCL2, CYP1B1, EGFR, ERBB2, F3, FLT3, GRM1, KDR, MET, PTPN1, SRC, XDH |
3.6792 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.6792 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.6792 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADRB1, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
3.66161 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADRB1, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
3.6485 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
3.64648 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADRB1, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
3.57152 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.53203 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CDK6, CYP1B1, EGFR, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RORC, SRC |
3.5046 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, SRC |
3.44457 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
3.44457 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.44457 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADRB1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, F3, FLT3, GRM1, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
3.44457 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
EGFR, GRM1, GRM3, GRM5, GRM8 |
3.42327 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.40634 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, MET, PIM1, SRC, TYR |
3.3995 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, XDH |
3.3995 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.37243 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, EGFR, ERBB2, PPARA |
3.29852 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, AXL, BCL2, CA2, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, F3, GRIK5, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC |
3.2453 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
3.2453 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
3.22297 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
3.21496 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
3.2001 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADRB1, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
3.2001 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADRB1, BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
3.2001 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, SRC |
3.2001 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, ADRB1, AXL, BCL2, CA2, CACNA1C, CDK6, CHRM2, CYP1B1, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F3, GRM1, KDR, MET, MMP12, MMP9, PIM1, SLC1A1, SRC, TNKS2, XDH |
3.19792 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.11519 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.11519 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.11519 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, EGFR, ESR1, PPARA, RORC, SRC |
3.0378 |
[BP] GO:0007193 |
None
|
CHRM2, GRM1, GRM3, GRM5, GRM8 |
2.99291 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.99163 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
2.97444 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
2.93501 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, MET, SRC, XDH |
2.91283 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
2.91161 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, BCL2, CDK6, CYP19A1, CYP1B1, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, SRC |
2.87061 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, HSD11B2, SRC |
2.81694 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.77837 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADRB1, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GRM1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.77613 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.75673 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, SLC1A1 |
2.74591 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, MET, SRC |
2.70447 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.699 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, ADRB1, AKR1B1, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, IGF1R, KDR, MET, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.6875 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2, SRC |
2.66789 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADRB1, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, GRM1, GRM5, MET, MMP9, PTPN1, SRC, TNKS, XDH |
2.66132 |
[BP] GO:0007188 |
None
|
ADRB1, CHRM2, GRM1, GRM3, GRM5, GRM8 |
2.66072 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, ADRB1, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MMP9, PTPN1, SRC, TNKS, XDH |
2.66072 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.63947 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH |
2.63573 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH |
2.62688 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.6149 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.5719 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH |
2.5719 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.56156 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA3, ADRB1, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, XDH |
2.52308 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TNKS, TNKS2 |
2.49423 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.49182 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, RORC, SRC |
2.49182 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.48769 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
BCL2, CDC25B, EGFR, ERBB2, ESRRB, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.48769 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
2.44152 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADRB1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, EGFR, GRM1, HSD11B2, MMP2, PPARA, SRC, TYR |
2.43576 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.43576 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CACNA1C, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, XDH |
2.42595 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9 |
2.42595 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.41331 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.4111 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.40399 |
[BP] GO:0007154 |
None
|
ADRB1, AXL, BCL2, CACNA1C, CHRM2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.40399 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, SRC |
2.40399 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.40399 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.40399 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.40399 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.39927 |
[BP] GO:0042325 |
regulation of phosphorylation
|
BCL2, CDC25B, EGFR, ERBB2, ESRRB, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.39927 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GBA2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
2.39043 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CDK6, CYP1A1, CYP1B1, EGFR, FABP3, HSD11B2, KDR, SRC |
2.3903 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.38911 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, ALPL, AXL, BCL2, CDC25B, CDK6, CYP1A1, EGFR, ERBB2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, MET, MMP2, MMP9, RORC, SRC |
2.38911 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC, TNKS |
2.38911 |
[BP] GO:0007187 |
None
|
ADRB1, CHRM2, GRM1, GRM3, GRM5, GRM8 |
2.38911 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PTPN1, SRC, TNKS, XDH |
2.38911 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, SRC |
2.34615 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9 |
2.3306 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.29093 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADRB1, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, MMP12, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
2.29093 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, EGFR, KDR, SRC |
2.29093 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.29093 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, EGFR, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, SRC, TYR |
2.28878 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.27031 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.27031 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADRB1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, ESR1, ESR2, F3, FLT3, GRM1, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
2.24732 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.2462 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, BCL2, CYP19A1, CYP1B1, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
2.23978 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TYR, XDH |
2.23294 |
[BP] GO:0007268 |
None
|
CHRM2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.22116 |
[BP] GO:0098916 |
None
|
CHRM2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.22116 |
[BP] GO:0042391 |
None
|
BCL2, CACNA1C, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.20616 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20243 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, KDR, SRC |
2.1949 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.18878 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.18878 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.18878 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.18878 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.18878 |
[BP] GO:0099536 |
None
|
CHRM2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.18164 |
[BP] GO:0099537 |
None
|
CHRM2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.18164 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.18164 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.18164 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.17925 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADRB1, AURKB, BCL2, CDC25B, EGFR, ERBB2, ESR1, F3, FLT3, GRM1, GRM5, PTPN1, SRC, TNKS, XDH |
2.17925 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17559 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, PPARA, RORC, SRC, TNKS, TNKS2 |
2.17212 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, KDR, SRC |
2.15953 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
BCL2, CDC25B, EGFR, ERBB2, FLT3, GRM1, GRM5, KDR, MMP9, PTPN1, SRC, XDH |
2.15545 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
2.14295 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, GRM1, GRM5 |
2.11628 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, SRC, TNKS, TNKS2 |
2.10978 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CACNA1C, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, TYR, XDH |
2.09421 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.08931 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.08931 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, SLC1A1 |
2.08931 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, EGFR, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, PPARA, SRC, TYR |
2.06842 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.05756 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, CDC25B, EGFR, ERBB2, FLT3, GRM1, GRM5, PTPN1, SRC, TNKS |
2.0487 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.0487 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.0487 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.04655 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, EGFR, HSD11B2, SRC, TYR |
2.03905 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.03079 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, HSD11B2 |
2.03079 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.03079 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.03079 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.03079 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.03079 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TNKS, TNKS2 |
2.02498 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CDK6, CYP19A1, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, XDH |
2.01611 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, TNKS, TNKS2 |
2.00905 |
[BP] GO:0023052 |
None
|
ADRB1, CACNA1C, CHRM2, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
2.00858 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CHRM2, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
3.6792 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ADRB1, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CACNA1C, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SRC, TNKS, TNKS2, TYR |
3.42451 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, ADRB1, ALPL, AXL, CA12, CA14, CA2, CA4, CACNA1C, CHRM2, CSNK2A1, EGFR, ERBB2, ESR1, F3, FLT3, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SRC |
3.39704 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.35665 |
[CC] GO:0097060 |
None
|
CHRM2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.00768 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA3, ADRB1, AXL, CA2, CA4, CACNA1C, CHRM2, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SRC |
2.69817 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, ADRB1, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CACNA1C, CHRM2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, MET, PTPN1, SLC1A1, SRC, TYR |
2.55655 |
[CC] GO:0044456 |
None
|
ACHE, CACNA1C, CHRM2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
2.54609 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, ADRB1, AXL, CA4, CHRM2, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1 |
2.48397 |
[CC] GO:0014069 |
None
|
CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.23294 |
[CC] GO:0099572 |
None
|
CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
2.23294 |
[CC] GO:0043235 |
receptor complex
|
EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, IGF1R |
2.03079 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
11.1585 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.74603 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
7.5715 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, ADRB1, AXL, CHRM2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, RORC |
7.52299 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, ADRB1, AXL, CDK6, CHRM2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, RORC |
7.1393 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, TYR, XDH |
6.92682 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, ADRB1, AXL, CHRM2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, RORC |
6.75477 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
6.27255 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, ADRB1, AXL, CHRM2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, RORC |
6.09191 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
5.90669 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.83925 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.20916 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.05674 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.05674 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
5.05402 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
4.99458 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.81876 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.67668 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, ADRB1, AXL, CHRM2, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
4.306 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, ADRB1, AXL, CHRM2, EGFR, ERBB2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
4.306 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.306 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.19904 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.15034 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TYR, XDH |
3.83961 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TYR, XDH |
3.6024 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.59586 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.54223 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.42183 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
3.3995 |
[MF] GO:0030594 |
None
|
CHRM2, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
3.3995 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.38241 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC |
3.27861 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.27289 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC |
3.23138 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.23138 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.22384 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.75673 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.75673 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.73191 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.66132 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.63573 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.60505 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARA, PTPN1 |
2.56496 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.49182 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.43576 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.40399 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.40399 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.39927 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.39927 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, SRC, XDH |
2.38911 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.37912 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PTPN1 |
2.27148 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.18878 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.18878 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.17752 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.16103 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, CSNK2A1, EGFR, ERBB2, ESR1, ESR2, FLT3, GRIK5, IGF1R, KDR, MET, MMP9, TYR, XDH |
2.09833 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.03785 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.03079 |